InnovAge Q2 Center-level Contribution Margin rises 42.5% to USD 52.83 million

Reuters
02/04
InnovAge <a href="https://laohu8.com/S/QTWO">Q2</a> Center-level Contribution Margin rises 42.5% to USD 52.83 million

InnovAge Holding Corporation reported its financial results for the fiscal second quarter ended December 31, 2025. Total revenues for the period were USD 239.71 million. Net income was USD 11.81 million, resulting in a net income margin of 4.9%. Net income attributable to shareholders was USD 10.62 million, with basic and diluted net income per share at USD 0.08. The company’s Center-level Contribution Margin was USD 52.83 million, an increase of 42.5%. Center-level Contribution Margin as a percentage of revenue rose by 4.3 points to 22.0%. Adjusted EBITDA grew to USD 22.20 million, up by USD 16.30 million. InnovAge’s CEO Patrick Blair stated that the quarter’s performance reflected disciplined execution and a care model emphasizing clinical outcomes, participant experience, and responsible stewardship of public resources. The company highlighted its focus on scalable growth, partnership with regulators, and creating long-term value for participants, payors, and shareholders.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. InnovAge Holding Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9647984-en) on February 03, 2026, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10